Cosmo Pharmaceuticals N.V.

SWX:COPN Lagerbericht

Marktkapitalisierung: CHF 1.0b

Cosmo Pharmaceuticals Management

Management Kriterienprüfungen 1/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Giovanni Di Napoli

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerless than a year
Eigentum des Geschäftsführersn/a
Durchschnittliche Amtszeit des Managements2.8yrs
Durchschnittliche Amtszeit der Vorstandsmitgliederless than a year

Jüngste Management Updates

Recent updates

Cosmo Pharmaceuticals N.V.'s (VTX:COPN) P/S Still Appears To Be Reasonable

Nov 22
Cosmo Pharmaceuticals N.V.'s (VTX:COPN) P/S Still Appears To Be Reasonable

Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

May 02
Market Participants Recognise Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Revenues

Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture

Mar 28
Cosmo Pharmaceuticals' (VTX:COPN) Weak Earnings May Only Reveal A Part Of The Whole Picture

Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher

Mar 26
Broker Revenue Forecasts For Cosmo Pharmaceuticals N.V. (VTX:COPN) Are Surging Higher

Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear

Dec 01
Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Popularity With Investors Is Clear

Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 29
Earnings Beat: Cosmo Pharmaceuticals N.V. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt

Nov 24
We Think Cosmo Pharmaceuticals (VTX:COPN) Can Stay On Top Of Its Debt

Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals

Mar 31
Cosmo Pharmaceuticals' (VTX:COPN) Solid Profits Have Weak Fundamentals

These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well

Aug 02
These 4 Measures Indicate That Cosmo Pharmaceuticals (VTX:COPN) Is Using Debt Reasonably Well

Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)

May 20
Increases to CEO Compensation Might Be Put On Hold For Now at Cosmo Pharmaceuticals N.V. (VTX:COPN)

Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly

Apr 03
Cosmo Pharmaceuticals (VTX:COPN) Seems To Use Debt Quite Sensibly

When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?

Mar 07
When Can We Expect A Profit From Cosmo Pharmaceuticals N.V. (VTX:COPN)?

Geschäftsführer

Giovanni Di Napoli (50 yo)

less than a year

Amtszeit

Mr. Giovanni Di Napoli is Chief Executive Officer and Director of Cosmo Pharmaceuticals N.V. from May 24, 2024. He was President of Gastrointestinal at Medtronic plc. He is an accomplished leader with an e...

Führungsteam

NamePositionAmtszeitVergütungEigentümerschaft
Alessandro Della Cha
Executive Chairman18.8yrs€1.16mkeine Daten
Niall Donnelly
Executive VP of Corporate Governanceno datakeine Datenkeine Daten
Giovanni Di Napoli
Chief Executive Officer & Directorless than a yearkeine Datenkeine Daten
Mauro Ajani
Founder & Non-Executive Director18.8yrs€400.00kkeine Daten
Svetlana Sigalova
Chief Financial Officerno datakeine Datenkeine Daten
Marco Lecchi
Chief Operating Officer3.8yrskeine Datenkeine Daten
Davide Malavasi
Qualified Person & Technical Director13.2yrskeine Datenkeine Daten
Luigi Longo
Chief Scientific Officer2.6yrskeine Datenkeine Daten
Hazel Winchester
Head of Investor Relations2.8yrskeine Datenkeine Daten
Biagio Vigano
Chief People Officer3.8yrskeine Datenkeine Daten
Roberto Villa
Chief Manufacturing Officer27.8yrskeine Datenkeine Daten
Ngo Nhan
President of Cosmo Intelligent Medical Devicesno datakeine Datenkeine Daten

2.8yrs

Durchschnittliche Betriebszugehörigkeit

52yo

Durchschnittliches Alter

Erfahrenes Management: COPNDas Führungsteam des Unternehmens gilt als erfahren (2.8 Jahre durchschnittliche Betriebszugehörigkeit).

Vorstandsmitglieder

NamePositionAmtszeitVergütungEigentümerschaft
Alessandro Della Cha
Executive Chairman18.8yrs€1.16mkeine Daten
Niall Donnelly
Executive VP of Corporate Governanceless than a yearkeine Datenkeine Daten
Giovanni Di Napoli
Chief Executive Officer & Directorless than a yearkeine Datenkeine Daten
Mauro Ajani
Founder & Non-Executive Director18.8yrs€400.00kkeine Daten
William Sandborn
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Geert D'Haens
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Silvio Danese
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Maria Roncarolo
Non-Executive Director12.6yrs€128.79kkeine Daten
Ralf Kiesslich
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Robert Steffen
Member of Scientific Advisory Boardno datakeine Datenkeine Daten
Silvana Perretta
Non-Executive Directorless than a yearkeine Datenkeine Daten
John O'Dea
Non-Executive Directorless than a yearkeine Datenkeine Daten

0.5yrs

Durchschnittliche Betriebszugehörigkeit

61yo

Durchschnittliches Alter

Erfahrener Vorstand: COPNDie Vorstandsmitglieder gelten nicht als erfahren ( 0.5 Jahre durchschnittliche Amtszeit), was auf einen neuen Vorstand hindeutet.